ColgatePalmolive (CL)
(Delayed Data from NYSE)
$90.77 USD
+0.55 (0.61%)
Updated Nov 7, 2024 03:59 PM ET
After-Market: $90.75 -0.02 (-0.02%) 4:42 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.77 USD
+0.55 (0.61%)
Updated Nov 7, 2024 03:59 PM ET
After-Market: $90.75 -0.02 (-0.02%) 4:42 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Zacks News
Colgate-Palmolive (CL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Colgate-Palmolive (CL) Matches Q4 Earnings Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 1.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Colgate (CL) is Well-Poised for Earnings Beat in Q4
by Zacks Equity Research
Colgate's (CL) Q4 results are expected to reflect gains from strong consumer demand, innovation, brand strength, and focus on premiumization and digital transformation.
Factors Likely to Influence Archer Daniels' (ADM) Q4 Earnings
by Zacks Equity Research
Archer Daniels (ADM) Q4 results are likely to reflect gains from solid demand, a strong Nutrition unit and efforts to expand its solutions portfolio. High costs and inflation are likely to have ailed.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 0.63% and 0.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Time to Buy These Consumer Staples Stocks Before Earnings?
by Shaun Pruitt
As we progress through earnings season, investors may want to pay attention to the Consumer Staples sector as there are quite a few stocks that could beat earnings expectations.
Factors Likely to Affect Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are likely to reflect the impacts of input cost inflation, higher freight, adverse product mix and increased packaging investments despite strong demand trends.
Will Colgate's (CL) Growth Strategies Aid Amid Cost Woes?
by Zacks Equity Research
Colgate (CL) is on track with its stringent pricing actions and accelerated revenue growth management plans. Higher raw material and logistic costs continue to hurt.
Colgate (CL) Q3 Earnings in Line, Higher Costs Hurt Outlook
by Zacks Equity Research
Gains from revenue growth management plans have led to pricing improvements across all regions, aiding Colgate???s (CL) Q3 results. Raw and packaging material, and logistic costs have hurt results.
Colgate-Palmolive (CL) Q3 Earnings Meet Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 0.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Colgate-Palmolive Q3 Preview: Back-To-Back EPS Beats Inbound?
by Derek Lewis
Colgate-Palmolive registered a slight 1.4% EPS beat in its latest print.
Can Colgate (CL) Beat Q3 Earnings Estimates Amid Cost Woes?
by Zacks Equity Research
Colgate's (CL) Q3 results are expected to reflect gains from strong demand, brand strength, innovation and digital growth, offset by higher raw material and logistic costs.
Clorox (CLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Colgate-Palmolive (CL) Q3 Earnings Expected to Decline
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 1.29% and 0.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Colgate-Palmolive (CL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Colgate-Palmolive (CL) closed the most recent trading day at $72.14, moving +1.14% from the previous trading session.
Brand Strength to Aid Colgate (CL) Despite High Inflation
by Zacks Equity Research
Despite rising raw material costs, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.
Colgate (CL) Cheers Investors With Dividend Amid Cost Woes
by Zacks Equity Research
Amid the rising cost concerns, Colgate (CL) rewards its shareholders with a dividend payment of 47 cents, payable on Nov 15, 2022.
Zacks Industry Outlook Highlights Colgate-Palmolive, Reckitt Benckiser Group and Henkel AG
by Zacks Equity Research
Colgate-Palmolive, Reckitt Benckiser Group and Henkel AG are part of Zacks Industry Outlook article.
3 Soaps & Cleaning Materials Stocks to Watch in a Troubled Industry
by Rajani Lohia
Soap and cleaning materials companies continue to struggle with elevated logistics, input and manufacturing costs amid supply-chain issues. Innovation and hygiene campaigns are likely to drive growth for players like Colgate (CL), Reckitt (RBGLY) and Henkel (HENKY).
Colgate (CL) Banks On Brand Strength Amid Cost Headwinds
by Zacks Equity Research
Despite rising raw material costs, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.
Beat the Market the Zacks Way: Dillard's (DDS), Sotherly Hotels (SOHO), Casey's (CASY) in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.
Top Research Reports for Berkshire Hathaway, Airbnb & Dominion Energy
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Airbnb, Inc. (ABNB) and Dominion Energy, Inc. (D).
Colgate (CL) Earnings & Sales Beat in Q2 on Pricing Plans
by Zacks Equity Research
Colgate's (CL) Q2 results gain from aggressive pricing actions and robust organic sales growth. Elevated raw and packaging material, and logistics costs, as well as adverse currency, act as woes.